In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs
- 1 July 2006
- Vol. 49 (4) , 324-330
- https://doi.org/10.1111/j.1439-0507.2006.01242.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada)Proceedings of the National Academy of Sciences, 2004
- Antifungal susceptibility of clinical and environmental isolates of Cryptococcus neoformans to four antifungal drugs determined by two techniquesMycoses, 2003
- (1557) Proposal to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus (Basidiomycota, Hymenomycetes, Tremellomycetidae)Taxon, 2002
- Hybrid genotypes in the pathogenic yeast Cryptococcus neoformansMicrobiology, 2001
- Cryptococcus neoformansvarietygattiiMedical Mycology, 2001
- Clinical features and in vitro susceptibilities of two varieties of Cryptococcus neoformans in TaiwanDiagnostic Microbiology and Infectious Disease, 2000
- Cryptococcosis at the University Hospital, Kuala LumpurTropical Doctor, 1998
- Serotyping of Cryptococcus neoformans strains isolated from clinical specimens in Thailand and their susceptibility to various antifungal agentsEuropean Journal of Epidemiology, 1997
- Serotypes of Cryptococcus neoformans isolated from patients prior to and during the AIDS era in ThailandMycopathologia, 1996
- Individual and Environmental Factors Associated with Infection Due to Cryptococcus neoformans Serotype DClinical Infectious Diseases, 1996